Epigenetic modifications: Basic mechanisms and role in cardiovascular disease

Circulation

Volumn 123, Issue 19, 2011, Pages 2145-2156

  Handy, Diane E ^a   Castro, Rita ^a,b   Loscalzo, Joseph ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF LISBON   (Portugal)

Author keywords

cardiovascular diseases; genes; metabolism; risk factors

Indexed keywords

DNA BINDING PROTEIN; DNA METHYLTRANSFERASE; HOMOCYSTEINE; RNA; UNTRANSLATED RNA;

ARTICLE; CARDIOVASCULAR DISEASE; CHROMATIN; CPG ISLAND; DNA METHYLATION; ENVIRONMENT; EPIGENETICS; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; INHERITANCE; NONHUMAN; NUTRITION; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CARDIOVASCULAR DISEASES; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HOMOCYSTEINE; HUMANS;

EID: 79957463780     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.956839     Document Type: Article

References (140)

1. Campos EI Reinberg D. Histones: annotating chromatin. Annu Rev Genet. 2009;43:559-599.
2. Fedorova E Zink D. Nuclear architecture and gene regulation. Biochim Biophys Acta. 2008;1783:2174-2184.
3. Bird AP. CpG-rich islands and the function of DNA methylation. Nature. 1986;321:209-213.
4. Lister R Pelizzola M Dowen RH Hawkins RD Hon G Tonti-Filippini J Nery JR Lee L Ye Z Ngo QM Edsall L Antosiewicz-Bourget J Stewart R Ruotti V Millar AH Thomson JA Ren B Ecker JR. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009;462:315-322.
5. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature. 2007;447:425-432.
6. Illingworth RS Bird AP. CpG islands: "a rough guide." FEBS Lett. 2009;583:1713-1720.
7. Shen L Kondo Y Guo Y Zhang J Zhang L Ahmed S Shu J Chen X Waterland RA Issa JP. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet. 2007;3:2023-2036.
8. Weber M Hellmann I Stadler MB Ramos L Paabo S Rebhan M Schubeler D. Distribution silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet. 2007; 39:457-466.
9. Nomura J Hisatsune A Miyata T Isohama Y. The role of CpG methylation in cell type-specific expression of the aquaporin-5 gene. Biochem Biophys Res Commun. 2007;353:1017-1022.
10. Aoyama T Okamoto T Nagayama S Nishijo K Ishibe T Yasura K Nakayama T Nakamura T Toguchida J. Methylation in the corepromoter region of the chondromodulin-I gene determines the cellspecific expression by regulating the binding of transcriptional activator Sp3. J Biol Chem. 2004;279:28789-28797.
11. Rossler J Stolze I Frede S Freitag P Schweigerer L Havers W Fandrey J. Hypoxia-induced erythropoietin expression in human neuroblastoma requires a methylation free HIF-1 binding site. J Cell Biochem. 2004;93:153-161.
12. Hendrich B Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol. 1998;18: 6538-6547.
13. Nan X Ng HH Johnson CA Laherty CD Turner BM Eisenman RN Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 1998;393: 386-389.
14. Wade PA Gegonne A Jones PL Ballestar E Aubry F Wolffe AP. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat Genet. 1999;23:62-66.
15. Okano M Bell DW Haber DA Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for De novo methylation and mammalian development. Cell. 1999;99:247-257.
16. Chen T Ueda Y Dodge JE Wang Z Li E. Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. Mol Cell Biol. 2003;23:5594-5605.
17. Liang G Chan MF Tomigahara Y Tsai YC Gonzales FA Li E Laird PW Jones PA. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol Cell Biol. 2002; 22:480-491.
18. Cirio MC Martel J Mann M Toppings M Bartolomei M Trasler J Chaillet JR. DNA methyltransferase 1o functions during preimplantation development to preclude a profound level of epigenetic variation. Dev Biol. 2008;324:139-150.
19. Leonhardt H Page AW Weier HU Bestor TH. A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell. 1992;71:865-873.
20. Orstavik KH. X chromosome inactivation in clinical practice. Hum Genet. 2009;126:363-373.
21. Butler MG. Genomic imprinting disorders in humans: a mini-review. J Assist Reprod Genet. 2009;26:477-486.
22. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature. 2007;447:433-440.
23. Chotalia M Smallwood SA Ruf N Dawson C Lucifero D Frontera M James K Dean W Kelsey G. Transcription is required for establishment of germline methylation marks at imprinted genes. Genes Dev. 2009; 23:105-117.
24. Green K Lewis A Dawson C Dean W Reinhart B Chaillet JR Reik W. A developmental window of opportunity for imprinted gene silencing mediated by DNA methylation and the Kcnq1ot1 noncoding RNA. Mamm Genome. 2007;18:32-42.
25. Wutz A Rasmussen TP Jaenisch R. Chromosomal silencing and localization are mediated by different domains of Xist RNA. Nat Genet. 2002;30:167-174.
26. Ciccone DN Su H Hevi S Gay F Lei H Bajko J Xu G Li E Chen T. KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. Nature. 2009;461:415-418.
27. Wang J Hevi S Kurash JK Lei H Gay F Bajko J Su H Sun W Chang H Xu G Gaudet F Li E Chen T. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet. 2009;41:125-129.
28. Popp C Dean W Feng S Cokus SJ Andrews S Pellegrini M Jacobsen SE Reik W. Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature. 2010;463: 1101-1105.
29. Wossidlo M Arand J Sebastiano V Lepikhov K Boiani M Reinhardt R Scholer H Walter J. Dynamic link of DNA demethylation DNA strand breaks and repair in mouse zygotes. EMBO J. 2010;29: 1877-1888.
30. Bird AP. DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res. 1980;8:1499-1504.
31. Kim MS Kondo T Takada I Youn MY Yamamoto Y Takahashi S Matsumoto T Fujiyama S Shirode Y Yamaoka I Kitagawa H Takeyama K Shibuya H Ohtake F Kato S. DNA demethylation in hormone-induced transcriptional derepression. Nature. 2009;461: 1007-1012.
32. Morgan HD Dean W Coker HA Reik W Petersen-Mahrt SK. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J Biol Chem. 2004;279:52353-52360.
33. Kangaspeska S Stride B Metivier R Polycarpou-Schwarz M Ibberson D Carmouche RP Benes V Gannon F Reid G. Transient cyclical methylation of promoter DNA. Nature. 2008;452:112-115.
34. Metivier R Gallais R Tiffoche C Le Peron C Jurkowska RZ Carmouche RP Ibberson D Barath P Demay F Reid G Benes V Jeltsch A Gannon F Salbert G. Cyclical DNA methylation of a transcriptionally active promoter. Nature. 2008;452:45-50.
35. Kouzarides T. Chromatin modifications and their function. Cell. 2007; 128:693-705.
36. Martin C Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol. 2005;6:838-849.
37. Jenuwein T Allis CD. Translating the histone code. Science. 2001;293: 1074-1080.
38. Strahl BD Allis CD. The language of covalent histone modifications. Nature. 2000;403:41-45.
39. Volkel P Angrand PO. The control of histone lysine methylation in epigenetic regulation. Biochimie. 2007;89:1-20.
40. McDonald OG Owens GK. Programming smooth muscle plasticity with chromatin dynamics. Circ Res. 2007;100:1428-1441.
41. Ooi L Belyaev ND Miyake K Wood IC Buckley NJ. BRG1 chromatin remodeling activity is required for efficient chromatin binding by repressor element 1-silencing transcription factor (REST) and facilitates REST-mediated repression. J Biol Chem. 2006;281:38974-38980.
42. Wu SY Chiang CM. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J Biol Chem. 2007;282: 13141-13145.
43. Berndsen CE Denu JM. Catalysis and substrate selection by histone/ protein lysine acetyltransferases. Curr Opin Struct Biol. 2008;18: 682-689.
44. Zimmermann N Acosta AM Kohlhase J Bartsch O. Confirmation of EP300 gene mutations as a rare cause of Rubinstein-Taybi syndrome. Eur J Hum Genet. 2007;15:837-842.
45. Petrij F Giles RH Dauwerse HG Saris JJ Hennekam RC Masuno M Tommerup N van Ommen GJ Goodman RH Peters DJ Breuning MH. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature. 1995;376:348-351.
46. Michan S Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J. 2007;404:1-13.
47. Mellert HS McMahon SB. Biochemical pathways that regulate acetyltransferase and deacetylase activity in mammalian cells. Trends Biochem Sci. 2009;34:571-578.
48. Codd R Braich N Liu J Soe CZ Pakchung AA. Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A. Int J Biochem Cell Biol. 2009;41:736-739.
49. Li J Wang J Wang J Nawaz Z Liu JM Qin J Wong J. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 2000;19:4342-4350.
50. Kao HY Downes M Ordentlich P Evans RM. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev. 2000;14:55-66.
51. Tsukada Y Fang J Erdjument-Bromage H Warren ME Borchers CH Tempst P Zhang Y. Histone demethylation by a family of JmjC domaincontaining proteins. Nature. 2006;439:811-816.
52. Metzger E Wissmann M Yin N Muller JM Schneider R Peters AH Gunther T Buettner R Schule R. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature. 2005;437:436-439.
53. Yamane K Toumazou C Tsukada Y Erdjument-Bromage H Tempst P Wong J Zhang Y. JHDM2A a JmjC-containing H3K9 demethylase facilitates transcription activation by androgen receptor. Cell. 2006;125: 483-495.
54. Sinha KM Yasuda H Coombes MM Dent SY De Crombrugghe B. Regulation of the osteoblast-specific transcription factor Osterix by NO66 a Jumonji family histone demethylase. EMBO J. 29:68-79.
55. Rinn JL Kertesz M Wang JK Squazzo SL Xu X Brugmann SA Goodnough LH Helms JA Farnham PJ Segal E Chang HY. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129:1311-1323.
56. Wagschal A Sutherland HG Woodfine K Henckel A Chebli K Schulz R Oakey RJ Bickmore WA Feil R. G9a histone methyltransferase contributes to imprinting in the mouse placenta. Mol Cell Biol. 2008; 28:1104-1113.
57. Nagano T Mitchell JA Sanz LA Pauler FM Ferguson-Smith AC Feil R Fraser P. The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science. 2008;322:1717-1720.
58. Mercer TR Dinger ME Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155-159.
59. Nagano T Fraser P. Emerging similarities in epigenetic gene silencing by long noncoding RNAs. Mamm Genome. 2009;20:557-562.
60. Ohnishi Y Totoki Y Toyoda A Watanabe T Yamamoto Y Tokunaga K Sakaki Y Sasaki H Hohjoh H. Small RNA class transition from siRNA/piRNA to miRNA during pre-implantation mouse development. Nucleic Acids Res. 2010;38:5141-5151.
61. Matzke MA Primig M Trnovsky J Matzke AJ. Reversible methylation and inactivation of marker genes in sequentially transformed tobacco plants. EMBO J. 1989;8:643-649.
62. Morris KV. RNA-directed transcriptional gene silencing and activation in human cells. Oligonucleotides. 2009;19:299-306.
63. Kim DH Villeneuve LM Morris KV Rossi JJ. Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat Struct Mol Biol. 2006;13:793-797.
64. Kim DH Saetrom P Snove O Jr Rossi JJ. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci USA. 2008;105:16230-16235.
65. Hawkins PG Santoso S Adams C Anest V Morris KV. Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells. Nucleic Acids Res. 2009;37:2984-2995.
66. Sinkkonen L Hugenschmidt T Berninger P Gaidatzis D Mohn F Artus-Revel CG Zavolan M Svoboda P Filipowicz W. MicroRNAs control De novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat Struct Mol Biol. 2008; 15:259-267.
67. Napoli S Pastori C Magistri M Carbone GM Catapano CV. Promoterspecific transcriptional interference and c-myc gene silencing by siRNAs in human cells. EMBO J. 2009;28:1708-1719.
68. Slatkin M. Epigenetic inheritance and the missing heritability problem. Genetics. 2009;182:845-850.
69. Manolio TA Collins FS Cox NJ Goldstein DB Hindorff LA Hunter DJ McCarthy MI Ramos EM Cardon LR Chakravarti A Cho JH Guttmacher AE Kong A Kruglyak L Mardis E Rotimi CN Slatkin M Valle D Whittemore AS Boehnke M Clark AG Eichler EE Gibson G Haines JL Mackay TF McCarroll SA Visscher PM. Finding the missing heritability of complex diseases. Nature. 2009;461:747-753.
70. Kong A Steinthorsdottir V Masson G Thorleifsson G Sulem P Besenbacher S Jonasdottir A Sigurdsson A Kristinsson KT Jonasdottir A Frigge ML Gylfason A Olason PI Gudjonsson SA Sverrisson S Stacey SN Sigurgeirsson B Benediktsdottir KR Sigurdsson H Jonsson T Benediktsson R Olafsson JH Johannsson OT Hreidarsson AB Sigurdsson G Ferguson-Smith AC Gudbjartsson DF Thorsteinsdottir U Stefansson K. Parental origin of sequence variants associated with complex diseases. Nature. 2009;462:868-874.
71. Ling C Poulsen P Simonsson S Ronn T Holmkvist J Almgren P Hagert P Nilsson E Mabey AG Nilsson P Vaag A Groop L. Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. J Clin Invest. 2007;117:3427-3435.
72. Barker DJ. The developmental origins of well-being. Philos Trans R Soc Lond B Biol Sci. 2004;359:1359-1366.
73. McMillen IC Robinson JS. Developmental origins of the metabolic syndrome: prediction plasticity and programming. Physiol Rev. 2005; 85:571-633.
74. Painter RC Roseboom TJ Bleker OP. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol. 2005;20: 345-352.
75. Godfrey KM Barker DJ. Fetal programming and adult health. Public Health Nutr. 2001;4:611-624.
76. Palinski W Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J. 2002;16:1348-1360.
77. Turunen MP Aavik E Yla-Herttuala S. Epigenetics and atherosclerosis. Biochim Biophys Acta. 2009;1790:886-891.
78. Weaver IC Cervoni N Champagne FA D'Alessio AC Sharma S Seckl JR Dymov S Szyf M Meaney MJ. Epigenetic programming by maternal behavior. Nat Neurosci. 2004;7:847-854.
79. Gluckman PD Hanson MA Buklijas T Low FM Beedle AS. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat Rev Endocrinol. 2009;5:401-408.
80. Kuzawa CW Sweet E. Epigenetics and the embodiment of race: developmental origins of US racial disparities in cardiovascular health. Am J Hum Biol. 2009;21:2-15.
81. Sherman RC Langley-Evans SC. Early administration of angiotensinconverting enzyme inhibitor captopril prevents the development of hypertension programmed by intrauterine exposure to a maternal lowprotein diet in the rat. Clin Sci (Lond). 1998;94:373-381.
82. Bogdarina I Welham S King PJ Burns SP Clark AJ. Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ Res. 2007;100:520-526.
83. Lillycrop KA Phillips ES Jackson AA Hanson MA Burdge GC. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr. 2005;135:1382-1386.
84. Lillycrop KA Slater-Jefferies JL Hanson MA Godfrey KM Jackson AA Burdge GC. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a proteinrestricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br J Nutr. 2007;97: 1064-1073.
85. Rouleau J Tanigawa G Szyf M. The mouse DNA methyltransferase 5-region: a unique housekeeping gene promoter. J Biol Chem. 1992; 267:7368-7377.
86. Das SK Chakrabarti R. Role of PPAR in cardiovascular diseases. Recent Pat Cardiovasc Drug Discov. 2006;1:193-209.
87. Walker BR. Glucocorticoids and cardiovascular disease. Eur J Endocrinol. 2007;157:545-559.
88. Jackson AA Dunn RL Marchand MC Langley-Evans SC. Increased systolic blood pressure in rats induced by a maternal low-protein diet is reversed by dietary supplementation with glycine. Clin Sci (Lond). 2002;103:633-639.
89. Torrens C Brawley L Anthony FW Dance CS Dunn R Jackson AA Poston L Hanson MA. Folate supplementation during pregnancy improves offspring cardiovascular dysfunction induced by protein restriction. Hypertension. 2006;47:982-987.
90. Burdge GC Lillycrop KA Phillips ES Slater-Jefferies JL Jackson AA Hanson MA. Folic acid supplementation during the juvenile-pubertal period in rats modifies the phenotype and epigenotype induced by prenatal nutrition. J Nutr. 2009;139:1054-1060.
91. Niculescu MD Craciunescu CN Zeisel SH. Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains. FASEB J. 2006;20:43-49.
92. Lv S Fan R Du Y Hou M Tang Z Ling W Zhu H. Betaine supplementation attenuates atherosclerotic lesion in apolipoprotein E-deficient mice. Eur J Nutr. 2009;48:205-212.
93. Post WS Goldschmidt-Clermont PJ Wilhide CC Heldman AW Sussman MS Ouyang P Milliken EE Issa JP. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res. 1999;43:985-991.
94. Kim J Kim JY Song KS Lee YH Seo JS Jelinek J Goldschmidt-Clermont PJ Issa JP. Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim Biophys Acta. 2007;1772:72-80.
95. Matouk CC Marsden PA. Epigenetic regulation of vascular endothelial gene expression. Circ Res. 2008;102:873-887.
96. Illi B Colussi C Grasselli A Farsetti A Capogrossi MC Gaetano C. NO sparks off chromatin: tales of a multifaceted epigenetic regulator. Pharmacol Ther. 2009;123:344-352.
97. Antoniades C Antonopoulos AS Tousoulis D Marinou K Stefanadis C. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J. 2009;30:6-15.
98. Joseph J Handy De Loscalzo J. Quo vadis: whither homocysteine research? Cardiovasc Toxicol. 2009;9:53-63.
99. Yi P Melnyk S Pogribna M Pogribny IP Hine RJ James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S- adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem. 2000;275:29318-29323.
100. Stern LL Mason JB Selhub J Choi SW. Genomic DNA hypomethylation a characteristic of most cancers is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev. 2000;9:849-853.
101. Friso S Choi SW Girelli D Mason JB Dolnikowski GG Bagley PJ Olivieri O Jacques PF Rosenberg IH Corrocher R Selhub J. A common mutation in the 510-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA. 2002;99:5606-5611.
102. Castro R Rivera I Blom HJ Jakobs C Tavares De Almeida I. Homocysteine metabolism hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis. 2006;29:3-20.
103. Kok RM Smith De Barto R Spijkerman AM Teerlink T Gellekink HJ Jakobs C Smulders YM. Global DNA methylation measured by liquid chromatography-tandem mass spectrometry: analytical technique reference values and determinants in healthy subjects. Clin Chem Lab Med. 2007;45:903-911.
104. Pogribny IP Beland FA. DNA hypomethylation in the origin and pathogenesis of human diseases. Cell Mol Life Sci. 2009;66:2249-2261.
105. Castro R Rivera I Struys EA Jansen EE Ravasco P Camilo ME Blom HJ Jakobs C Tavares De Almeida I. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem. 2003;49:1292-1296.
106. Lund G Andersson L Lauria M Lindholm M Fraga MF Villar-Garea A Ballestar E Esteller M Zaina S. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem. 2004;279:29147-29154.
107. Devlin AM Arning E Bottiglieri T Faraci FM Rozen R Lentz SR. Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice. Blood. 2004;103:2624-2629.
108. Devlin AM Bottiglieri T Domann FE Lentz SR. Tissue-specific changes in H19 methylation and expression in mice with hyperhomocysteinemia. J Biol Chem. 2005;280:25506-25511.
109. Sharma P Kumar J Garg G Kumar A Patowary A Karthikeyan G Ramakrishnan L Brahmachari V Sengupta S. Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol. 2008;27:357-365.
110. Ingrosso D Cimmino A Perna AF Masella L De Santo NG De Bonis ML Vacca M D'Esposito M D'Urso M Galletti P Zappia V. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet. 2003;361:1693-1699.
111. Nanayakkara PW Kiefte-de Jong JC Stehouwer CD van Ittersum FJ Olthof MR Kok RM Blom HJ van Guldener C ter Wee PM Smulders YM. Association between global leukocyte DNA methylation renal function carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease. Nephrol Dial Transplant. 2008;23:2586-2592.
112. Stenvinkel P Karimi M Johansson S Axelsson J Suliman M Lindholm B Heimburger O Barany P Alvestrand A Nordfors L Qureshi AR Ekstrom TJ Schalling M. Impact of inflammation on epigenetic DNA methylation: a novel risk factor for cardiovascular disease? J Intern Med. 2007;261:488-499.
113. Ingrosso D Perna AF. Epigenetics in hyperhomocysteinemic states: a special focus on uremia. Biochim Biophys Acta. 2009;1790:892-899.
114. Movassagh M Choy MK Goddard M Bennett MR Down TA Foo RS. Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PLoS One. 2010;5:e8564.
115. Perna AF Ingrosso D Violetti E Luciano MG Sepe I Lanza D Capasso R Ascione E Raiola I Lombardi C Stenvinkel P Massy Z De Santo NG. Hyperhomocysteinemia in uremia: a red flag in a disrupted circuit. Semin Dial. 2009;22:351-356.
116. Wang H Yoshizumi M Lai K Tsai JC Perrella MA Haber E Lee ME. Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem. 1997;272: 25380-25385.
117. Wang H Jiang X Yang F Chapman GB Durante W Sibinga NE Schafer AI. Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition. Blood. 2002;99:939-945.
118. Jamaluddin MD Chen I Yang F Jiang X Jan M Liu X Schafer AI Durante W Yang X Wang H. Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood. 2007; 110:3648-3655.
119. Chang PY Lu SC Lee CM Chen YJ Dugan TA Huang WH Chang SF Liao WS Chen CH Lee YT. Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation. Circ Res. 2008;102:933-941.
120. Yideng J Jianzhong Z Ying H Juan S Jinge Z Shenglan W Xiaoqun H Shuren W. Homocysteine-mediated expression of SAHH DNMTs MBD2 and DNA hypomethylation potential pathogenic mechanism in VSMCs DNA. Cell Biol. 2007;26:603-611.
121. Lenz B Bleich S Beutler S Schlierf B Schwager K Reulbach U Kornhuber J Bonsch D. Homocysteine regulates expression of Herp by DNA methylation involving the AARE and CREB binding sites. Exp Cell Res. 2006;312:4049-4055.
122. Huang YS Zhi YF Wang SR. Hypermethylation of estrogen receptor-alpha gene in atheromatosis patients and its correlation with homocysteine. Pathophysiology. 2009;16:259-265.
123. Werstuck GH Lentz SR Dayal S Hossain GS Sood SK Shi YY Zhou J Maeda N Krisans SK Malinow MR Austin RC. Homocysteineinduced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest. 2001;107: 1263-1273.
124. Namekata K Enokido Y Ishii I Nagai Y Harada T Kimura H. Abnormal lipid metabolism in cystathionine beta-synthase-deficient mice an animal model for hyperhomocysteinemia. J Biol Chem. 2004; 279:52961-52969.
125. Jacobson TA Miller M Schaefer EJ. Hypertriglyceridemia and cardiovascular risk reduction. Clin Ther. 2007;29:763-777.
126. Mikael LG Wang XL Wu Q Jiang H Maclean KN Rozen R. Hyperhomocysteinemia is associated with hypertriglyceridemia in mice with methylenetetrahydrofolate reductase deficiency. Mol Genet Metab. 2009;98:187-194.
127. Devlin AM Lentz SR. ApoA-I: a missing link between homocysteine and lipid metabolism? Circ Res. 2006;98:431-433.
128. Mikael LG Genest J Jr Rozen R. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ Res. 2006;98:564-571.
129. Liao D Tan H Hui R Li Z Jiang X Gaubatz J Yang F Durante W Chan L Schafer AI Pownall HJ Yang X Wang H. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I protein synthesis and enhancing HDL cholesterol clearance. Circ Res. 2006;99:598-606.
130. Liao D Yang X Wang H. Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease. Clin Chem Lab Med. 2007;45:1652-1659.
131. Devlin AM Singh R Wade RE Innis SM Bottiglieri T Lentz SR. Hypermethylation of Fads2 and altered hepatic fatty acid and phospholipid metabolism in mice with hyperhomocysteinemia. J Biol Chem. 2007;282:37082-37090.
132. Devlin AM Singh R Bottiglieri T Innis SM Green TJ. Hepatic acylcoenzyme A:cholesterol acyltransferase-2 expression is decreased in mice with hyperhomocysteinemia. J Nutr. 2010;140:231-237.
133. Fraga MF Ballestar E Paz MF Ropero S Setien F Ballestar ML Heine-Suner D Cigudosa JC Urioste M Benitez J Boix-Chornet M Sanchez-Aguilera A Ling C Carlsson E Poulsen P Vaag A Stephan Z Spector TD Wu YZ Plass C Esteller M. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA. 2005;102:10604-10609.
134. Saunthararajah Y Hillery CA Lavelle D Molokie R Dorn L Bressler L Gavazova S Chen YH Hoffman R DeSimone J. Effects of 5-aza-2-deoxycytidine on fetal hemoglobin levels red cell adhesion and hematopoietic differentiation in patients with sickle cell disease. Blood. 2003;102:3865-3870.
135. Garzon R Liu S Fabbri M Liu Z Heaphy CE Callegari E Schwind S Pang J Yu J Muthusamy N Havelange V Volinia S Blum W Rush LJ Perrotti D Andreeff M Bloomfield CD Byrd JC Chan K Wu LC Croce CM Marcucci G. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood. 2009;113:6411-6418.
136. Bieliauskas AV Pflum MK. Isoform-selective histone deacetylase inhibitors. Chem Soc Rev. 2008;37:1402-1413.
137. Pons D De Vries FR Van Den Elsen PJ Heijmans BT Quax PH Jukema JW. Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease. Eur Heart J. 2009; 30:266-277.
138. Willyard C. The saving switch. Nat Med. 2010;16:18-21.
139. Zhong L D'Urso A Toiber D Sebastian C Henry RE Vadysirisack DD Guimaraes A Marinelli B Wikstrom JD Nir T Clish CB Vaitheesvaran B Iliopoulos O Kurland I Dor Y Weissleder R Shirihai OS Ellisen LW Espinosa JM Mostoslavsky R. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell. 2010;140: 280-293.
140. Holliday R. Epigenetics: a historical overview. Epigenetics. 2006; 1:76-80.